Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 3/20 | 0.64 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.64 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.64 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.64 |
| ▸ | LTA4H | P09960 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 5/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | GLA | P06280 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5312758 | 0.89 | LTA4H (0.70) | CHRNB4CHRNA3CHRNB2CHRNA4LTA4H | |
| SCHEMBL5309852 | 0.85 | LTA4H (0.71) | CHRNB4CHRNA3CHRNB2CHRNA4LTA4H | |
| SCHEMBL5658691 | 0.80 | LMNA (0.74) | CHRNB4CHRNA3CHRNB2CHRNA4LTA4H | |
| SCHEMBL5312991 | 0.79 | LTA4H (0.80) | LTA4HLMNASMN1; SMN2GAAMAPT | |
| SCHEMBL1001319 | 0.79 | ALDH1A1 (0.81) | LMNASMN1; SMN2GAAMAPTALDH1A1 | |
| SCHEMBL5663465 | 0.78 | LTA4H (0.66) | LTA4HLMNASMN1; SMN2GAAMAPT | |
| SCHEMBL5314323 | 0.77 | LTA4H (0.64) | LTA4HLMNASMN1; SMN2GAAMAPT | |
| SCHEMBL5661871 | 0.76 | ALDH1A1 (0.69) | CHRNB4CHRNA3CHRNB2CHRNA4LTA4H | |
| SCHEMBL5317908 | 0.76 | LTA4H (1.00) | LTA4HLMNASMN1; SMN2GAAMAPT | |
| SCHEMBL5315377 | 0.76 | LTA4H (0.76) | LTA4HLMNASMN1; SMN2GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007079003-A2 | AMIDE INHIBITORS OF LEUKOTRIENE A4 HYDROLASE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-07-12 | — | — | WO | disclosed |
| US-20070155727-A1 | Amide inhibitors of leukotriene A4 hydrolase | SCHERING AKTIENGESSELLSCHAFT (DE) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070155727-A1 | Amide inhibitors of leukotriene A4 hydrolase | LTA4H, LTB4R, LTC4S | CHRNB4 1080/4885CHRNA3 1485/4885CHRNB2 2083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.